Arkolith/Insider Trading/RAIN/Form 4

Biotechnology Value Fund II LP

DirectorRain Oncology Inc. (RAIN) · full profile →Form 4 · filed Jan 29, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 25, 2024Tender(U)1.4M——0
Jan 25, 2024Tender(U)2.9M——0
Jan 25, 2024Tender(U)2.1M——0
Jan 25, 2024Tender(U)1.7M——0
Jan 25, 2024Tender(U)342K——0
Jan 25, 2024Tender(U)185K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 26, 2024Disposed to issuer(D)35K——0
Jan 26, 2024Disposed to issuer(D)20K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193805-24-000107) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Rain Oncology Inc.

Build

Ask your agent about RAIN insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193805-24-000107"
Ask your agent
Use Arkolith to summarize insider buying and selling at Rain Oncology Inc.
over the last 90 days and cite the filings.